172 related articles for article (PubMed ID: 18325535)
1. Relapsing Guillain Barré Syndrome and nephrotic syndrome secondary to focal segmental glomerulosclerosis.
Souayah N; Cros D; Stein TD; Chong PS
J Neurol Sci; 2008 Jul; 270(1-2):184-8. PubMed ID: 18325535
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory demyelinating neuropathies with focal segmental glomerulosclerosis: Two case reports.
Mao Y; Zhang M; Liu S; Xu Y; Xue J; Hao C; Lai L
Medicine (Baltimore); 2018 Dec; 97(49):e13304. PubMed ID: 30544390
[TBL] [Abstract][Full Text] [Related]
3. Adding plasmapheresis to corticosteroids and alkylating agents: does it benefit patients with focal segmental glomerulosclerosis?
Mitwalli AH
Nephrol Dial Transplant; 1998 Jun; 13(6):1524-8. PubMed ID: 9641186
[TBL] [Abstract][Full Text] [Related]
4. Papulonodular mucinosis, Guillain-Barré syndrome and nephrotic syndrome in a patient with systemic lupus erythematosus: a case report.
Su X; Qiao X; Li J; Gao L; Wang C; Wang L
BMC Nephrol; 2017 Feb; 18(1):43. PubMed ID: 28143420
[TBL] [Abstract][Full Text] [Related]
5. Focal segmental glomerulosclerosis and Guillain-Barre syndrome associated with Campylobacter enteritis.
Lim A; Lydia A; Rim H; Dowling J; Kerr P
Intern Med J; 2007 Oct; 37(10):724-8. PubMed ID: 17894770
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Guillain-Barré syndrome.
McNair ND
J Infus Nurs; 2013; 36(6):397-400. PubMed ID: 24202119
[TBL] [Abstract][Full Text] [Related]
7. Corticosteroid-resistant nephrotic syndrome with focal and segmental glomerulosclerosis : an update of treatment options for children.
Ehrich JH; Pape L; Schiffer M
Paediatr Drugs; 2008; 10(1):9-22. PubMed ID: 18162004
[TBL] [Abstract][Full Text] [Related]
8. Focal segmental glomerulosclerosis with idiopathic nephrotic syndrome: three types of clinical response.
Arbus GS; Poucell S; Bacheyie GS; Baumal R
J Pediatr; 1982 Jul; 101(1):40-5. PubMed ID: 7045316
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of Guillain-Barré Syndrome].
Nomura K
Brain Nerve; 2015 Nov; 67(11):1397-410. PubMed ID: 26560955
[TBL] [Abstract][Full Text] [Related]
10. Current therapeutic options in severe Guillain-Barré syndrome.
Shahar E
Clin Neuropharmacol; 2006; 29(1):45-51. PubMed ID: 16518134
[TBL] [Abstract][Full Text] [Related]
11. Focal Segmental Glomerular Sclerosis Ameliorated by Long-term Hemodialysis Therapy with Low-density Lipoprotein Apheresis.
Araki H; Ono S; Nishizawa Y; Deji N; Nakazawa J; Morita Y; Kume S; Chin-Kanasaki M; Isshiki K; Araki S; Arimura T; Maegawa H; Uzu T
Intern Med; 2015; 54(17):2213-7. PubMed ID: 26328649
[TBL] [Abstract][Full Text] [Related]
12. Successful Treatment of Nephrotic Syndrome Due to Collapsing Focal Segmental Glomerulosclerosis Accompanied by Acute Interstitial Nephritis.
Shima H; Doi T; Okamoto T; Higashiguchi Y; Harada M; Inoue T; Tashiro M; Wariishi S; Takamatsu N; Kawahara K; Okada K; Minakuchi J
Intern Med; 2022 Jun; 61(12):1863-1867. PubMed ID: 34803098
[TBL] [Abstract][Full Text] [Related]
13. Therapy-resistant focal and segmental glomerulosclerosis.
Kveder R
Nephrol Dial Transplant; 2003 Jul; 18 Suppl 5():v34-7. PubMed ID: 12817066
[TBL] [Abstract][Full Text] [Related]
14. Renal ablation using bilateral renal artery embolization for treatment of resistant nephrotic syndrome.
Sallam HE; El-Reshaid K; Varro J
Saudi J Kidney Dis Transpl; 2012 Nov; 23(6):1258-61. PubMed ID: 23168861
[TBL] [Abstract][Full Text] [Related]
15. Long-term complete remission in a patient with focal segmental glomerulosclerosis associated with Guillain-Barre syndrome.
Aratani S; Mii A; Yuzawa R; Morita M; Kumagai T; Sakai Y; Shimizu A; Tsuruoka S
Nephrology (Carlton); 2017 Oct; 22(10):821. PubMed ID: 28921751
[No Abstract] [Full Text] [Related]
16. Guillain-Barré Syndrome secondary to tacrolimus in a patient with corticoresistant nephrotic syndrome caused by focal and segmental glomerulonephritis and IgA nephropathy.
Romaniouk Jakovler I; Perez Nieto C; Romero Antonio M; Simal Blanco F; Mouzo Javier R
Nefrologia (Engl Ed); 2018; 38(6):665-667. PubMed ID: 29246388
[No Abstract] [Full Text] [Related]
17. Inefficacy and toxicity of pefloxacin in focal and segmental glomerulosclerosis with steroid-resistant nephrotic syndrome.
Geffriaud-Ricouard C; Jungers P; Chauveau D; Grünfeld JP
Lancet; 1993 Jun; 341(8858):1475. PubMed ID: 8099164
[No Abstract] [Full Text] [Related]
18. Therapeutic trial of low density lipoprotein apheresis (LDL-A) in conjunction with double filtration plasmapheresis (DFPP) in drug-resistant nephrotic syndrome due to focal glomerular sclerosis (FGS).
Tojo K; Sakai S; Miyahara T
Prog Clin Biol Res; 1990; 337():193-4. PubMed ID: 2191313
[No Abstract] [Full Text] [Related]
19. Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis.
McCarthy ET; Sharma M; Savin VJ
Clin J Am Soc Nephrol; 2010 Nov; 5(11):2115-21. PubMed ID: 20966123
[TBL] [Abstract][Full Text] [Related]
20. Focal Segmental Glomerulosclerosis: State-of-the-Art and Clinical Perspective.
Shabaka A; Tato Ribera A; Fernández-Juárez G
Nephron; 2020; 144(9):413-427. PubMed ID: 32721952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
